Where Will TransMedics Group Stock Be in 10 Years?
Key takeaways
- TMDX Every year in the United States, roughly 100,000 people sit on transplant waiting lists.
- Trans Medics Group (NASDAQ: TMDX) is dismantling that constraint, and almost nobody is talking about it in the way they should be.
- In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia.
TMDX Every year in the United States, roughly 100,000 people sit on transplant waiting lists. Some will wait years. Others won't make it. The problem isn't only a shortage of willing donors; it's that the organs that do become available often don't survive long enough to reach the right recipient. The traditional method of packing organs on ice gives surgeons a brutal clock to work against: A harvested heart, for example, may only have four to six hours before it's no longer viable.
Trans Medics Group (NASDAQ: TMDX) is dismantling that constraint, and almost nobody is talking about it in the way they should be. TransMedics makes the Organ Care System (OCS), a portable machine that keeps donor organs warm, perfused with oxygenated blood, and in a functional metabolic state -- essentially keeping them alive outside the body during transport. Instead of racing the clock, surgeons can assess organ quality in real time before committing to a transplant. That changes everything about how transplant medicine works.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »